Skip to main content

Table 3 VAS improvement (FAS)

From: Nalfurafine hydrochloride for refractory pruritus in peritoneal dialysis patients: a phase III, multi-institutional, non-controlled, open-label trial

 

Treatment period week 1

(days 1–7)

(N = 37)

Treatment period week 2

(days 8–14)

(N = 36)

Treatment period week 3

(days 15–21)

(N = 35)

Treatment period week 4

(days 22–28)

(N = 35)

Follow-up period week 1

(days 1–8)

(N = 36)

Improved patients (%) [95% CI]

11 (29.7) [15.9, 47.0]

18 (50.0) [32.9, 67.1]

22 (62.9) [44.9, 78.5]

22 (62.9) [44.9, 78.5]

19 (52.8) [35.5, 69.6]